Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Ueberall

Efficacy and Tolerability Balance of Oxycodone/Naloxone and Tapentadol in Chronic Low Back Pain With a Neuropathic Component: A Blinded End Point Analysis of Randomly Selected Routine Data From 12-Week Prospective Open-Label Observations

Journal of Pain Research

Anesthesiology

Pain Medicine

2016

English

Development of Opioid-Induced Constipation: Post Hoc Analysis of Data From a 12-Week Prospective, Open-Label, Blinded-Endpoint Streamlined Study in Low-Back Pain Patients Treated With Prolonged-Release WHO Step III Opioids [Corrigendum]

Journal of Pain Research

Anesthesiology

Pain Medicine

2015

English

Development of Opioid-Induced Constipation: Post Hoc Analysis of Data From a 12-Week Prospective, Open-Label, Blinded-Endpoint Streamlined Study in Low-Back Pain Patients Treated With Prolonged-Release WHO Step III Opioids

Journal of Pain Research

Anesthesiology

Pain Medicine

2015

English

Related publications

Kinase Domain Mutations Confer Resistance to Novel Inhibitors Targeting JAK2V617F in Myeloproliferative Neoplasms

English

DNMT3A and IDH Mutations in Acute Myeloid Leukemia and Other Myeloid Malignancies: Associations With Prognosis and Potential Treatment Strategies

English

Loss of Dnmt3a and Endogenous KrasG12D/+ Cooperate to Regulate Hematopoietic Stem and Progenitor Cell Functions in Leukemogenesis

English

High Risks of Familial Chronic Lymphatic Leukemia for Specific Relatives: Signposts for Genetic Discovery?

English

miR-194-5p/BCLAF1 Deregulation in AML Tumorigenesis

English

Bortezomib and Dexamethasone Consolidation Following Risk-Adapted Melphalan and Stem Cell Transplantation for Patients With Newly Diagnosed Light-Chain Amyloidosis

English

The Use of Low-Dose Alemtuzumab in Pretreated B-Cell Chronic Lymphocytic Leukemia

English

A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T Lymphocytes in T Cells of Smoldering Myeloma Patients

English

A Phase 1 Study of Concomitant High-Dose Lenalidomide and 5-Azacitidine Induction in the Treatment of AML

English

Polymorphism of the Erythropoietin Gene Promotor and the Development of Myelodysplastic Syndromes Subsequent to Multiple Myeloma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Ueberall

Efficacy and Tolerability Balance of Oxycodone/Naloxone and Tapentadol in Chronic Low Back Pain With a Neuropathic Component: A Blinded End Point Analysis of Randomly Selected Routine Data From 12-Week Prospective Open-Label Observations

Development of Opioid-Induced Constipation: Post Hoc Analysis of Data From a 12-Week Prospective, Open-Label, Blinded-Endpoint Streamlined Study in Low-Back Pain Patients Treated With Prolonged-Release WHO Step III Opioids [Corrigendum]

Development of Opioid-Induced Constipation: Post Hoc Analysis of Data From a 12-Week Prospective, Open-Label, Blinded-Endpoint Streamlined Study in Low-Back Pain Patients Treated With Prolonged-Release WHO Step III Opioids

Related publications

Kinase Domain Mutations Confer Resistance to Novel Inhibitors Targeting JAK2V617F in Myeloproliferative Neoplasms

DNMT3A and IDH Mutations in Acute Myeloid Leukemia and Other Myeloid Malignancies: Associations With Prognosis and Potential Treatment Strategies

Loss of Dnmt3a and Endogenous KrasG12D/+ Cooperate to Regulate Hematopoietic Stem and Progenitor Cell Functions in Leukemogenesis

High Risks of Familial Chronic Lymphatic Leukemia for Specific Relatives: Signposts for Genetic Discovery?

miR-194-5p/BCLAF1 Deregulation in AML Tumorigenesis

Bortezomib and Dexamethasone Consolidation Following Risk-Adapted Melphalan and Stem Cell Transplantation for Patients With Newly Diagnosed Light-Chain Amyloidosis

The Use of Low-Dose Alemtuzumab in Pretreated B-Cell Chronic Lymphocytic Leukemia

A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T Lymphocytes in T Cells of Smoldering Myeloma Patients

A Phase 1 Study of Concomitant High-Dose Lenalidomide and 5-Azacitidine Induction in the Treatment of AML

Polymorphism of the Erythropoietin Gene Promotor and the Development of Myelodysplastic Syndromes Subsequent to Multiple Myeloma